Combined Hormonal Contraceptive Use in High Risk Women: A Longitudinal Study
NCT ID: NCT00361400
Last Updated: 2013-08-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1387 participants
OBSERVATIONAL
2005-08-31
2008-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
NCT00362479
Long-Acting Reversible Contraception
NCT01299116
A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods
NCT00253019
A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy
NCT00996580
Trial of Immediate Versus Delayed Initiation of Oral Contraceptive Pills After Abortion
NCT00235534
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
15 Years
24 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tina R Raine, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Cynthia Harper, PhD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Planned Parenthood-Golden Gate
Hayward, California, United States
Planned Parenthood-Golden Gate
Oakland, California, United States
Planned Parenthood - Shasta Diablo
Richmond, California, United States
University of California, San Francisco
San Francisco, California, United States
Planned Parenthood - Shasta Diablo
Vallejo, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.